NGS Solutions for All
AmpSeq (ampseq.com) earns a Brand Analyzer score of 69 out of 100, placing it in the Developing tier among Healthcare brands, Technology brands. Among 2305 Healthcare brands analyzed, AmpSeq ranks in the 56th percentile (category average 68, leader 95). The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark. Dimension scores: Name Quality 92/100, Digital Presence 82/100, Visual Identity 90/100, Messaging Clarity 95/100, Trust Foundation 78/100, AI Discoverability 80/100, Brand Authority 6/100.
AmpSeq is a next-generation sequencing (NGS) service provider operating labs in Boston, Maryland, and Connecticut. The company offers end-to-end NGS solutions encompassing RNA-seq, genomic sequencing, and targeted sequencing, spanning sample extraction, library preparation, sequencing, and data analysis. AmpSeq serves projects at any sample scale and provides real-time project tracking through the AmpSeq Portal. Its stated mission is to make NGS accessible to all researchers.
| Brand Name | AmpSeq |
|---|---|
| Domain | ampseq.com |
| Industry | Healthcare, Technology |
| Main Competitors | Novogene, Genewiz (Azenta Life Sciences), Psomagen, CD Genomics, Macrogen, Admera Health |
Moz Domain Authority 8/100 vs category average 29 / leader 95 - limited third-party links, so AI systems rarely encounter mentions of the brand.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "AmpSeq is a leading next-generation sequencing (NGS) service provider. We provide comprehensive NGS solutions including RNA-seq, genomic sequencing, and targeted sequencing, with i…" (Meta description: 59 words. OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 3 JSON-LD block(s), Organization schema, Breadcrumb/Website schema, og:title, og:description, og:type, Twitter cards, canonical. Adding FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Social footprint: verified profiles on LinkedIn, Instagram, YouTube, GitHub; no detected presence on X (Twitter), Facebook - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
AmpSeq scores 21/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
AmpSeq has a weak AI-visibility profile at 21/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (45/100) and its weakest is visibility (0/100). It benefits from open access for AI crawlers (GPTBot, ClaudeBot, etc.) and machine-readable schema.org markup. The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, no strong Wikidata entry and a low Moz Domain Authority of 8/100.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
AmpSeq offers a suite of next-generation sequencing services including RNA-seq (transcriptome sequencing), genomic sequencing, and targeted sequencing. Beyond sequencing itself, the company provides supporting services such as sample extraction, library preparation, and bioinformatic data analysis, covering the full NGS workflow. These services are available at any sample scale. AmpSeq also provides the AmpSeq Portal, a platform enabling clients to track their projects in real time.
Sources: AmpSeq official site
AmpSeq's main competitors include Novogene, Genewiz (Azenta Life Sciences), Psomagen, CD Genomics, Macrogen. These companies compete in the Healthcare space for similar customers, offering comparable products or services.
Sources: AmpSeq official site
AmpSeq is a next-generation sequencing (NGS) service provider with laboratory facilities in Boston, Maryland, and Connecticut. The company describes itself as a leading provider of comprehensive NGS solutions, with a mission to make NGS accessible to all. It operates across the healthcare and technology sectors and offers services at any sample scale, supported by an online project tracking platform called the AmpSeq Portal.
Sources: AmpSeq official site
AmpSeq provides end-to-end next-generation sequencing services, supporting research projects from initial sample extraction and library preparation through sequencing and downstream data analysis. The company offers specific sequencing modalities including RNA-seq, genomic sequencing, and targeted sequencing. Projects can be handled at any sample scale. AmpSeq also provides real-time project tracking through its proprietary AmpSeq Portal, streamlining communication and workflow management for clients.
Sources: AmpSeq official site
Popular alternatives to AmpSeq include Novogene, Genewiz (Azenta Life Sciences), Psomagen, CD Genomics, Macrogen. Each is an established option in the Healthcare space; the best fit depends on your specific needs, budget, and required features.
Sources: AmpSeq official site
AmpSeq has low AI-search visibility, scoring 21/100 on Brand Analyzer's AI visibility composite (visibility 0, trust 34, recommendation 45). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: AmpSeq official site
AmpSeq and Novogene are competitors in Healthcare. They target overlapping audiences; the right choice depends on your specific needs and priorities.
Sources: AmpSeq official site
AmpSeq scores 45/100 on Brand Analyzer's AI recommendation signal, indicating it is less likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: AmpSeq official site
AmpSeq is known for providing comprehensive, end-to-end next-generation sequencing solutions with industry-leading turnaround times. The company emphasizes accessibility of NGS services, supporting projects at any scale from sample extraction to data analysis. It is also noted for offering real-time project tracking via the AmpSeq Portal and for operating multiple laboratory locations across the northeastern United States, including Boston, Maryland, and Connecticut.
Sources: AmpSeq official site
AmpSeq's services are targeted at research laboratories and scientists who require next-generation sequencing capabilities. This includes users needing specific sequencing applications such as RNA-seq, genomic sequencing, or targeted sequencing. The company's stated mission to make NGS accessible to all suggests it aims to serve a broad range of research teams, from large institutions to smaller labs that may benefit from outsourcing sequencing workflows.
Sources: AmpSeq official site
AmpSeq can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: AmpSeq official site
Ranked closest to AmpSeq: Aegis Therapies (69/100), ActivityPro (69/100), Armor Dental (69/100), Assil Gaur Eye Institute (69/100).
A step up - brands to learn from: Zipari by mPulse (71/100), Zaina AI (71/100).
Category leader: Dassault Systèmes (95/100).